Amanote Research
Register
Sign In
Imatinib for the Treatment of Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumours: Systematic Review and Economic Evaluation
Health Technology Assessment
- United Kingdom
doi 10.3310/hta9250
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Date
July 1, 2005
Authors
J Wilson
M Connock
F Song
G Yao
A Fry-Smith
J Raftery
D Peake
Publisher
National Institute for Health Research
Related search
Phase II Trial of Imatinib in Metastatic or Unresectable Gastrointestinal Stromal Tumors,NEMROCK Experience.
Research in Oncology
Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors
Journal of Gastrointestinal Surgery
Surgery
Gastroenterology
Everolimus, Lutetium-177 DOTATATE and Sunitinib for Advanced, Unresectable or Metastatic Neuroendocrine Tumours With Disease Progression: A Systematic Review and Cost-Effectiveness Analysis
Health Technology Assessment
Medicine
Health Policy
Systematic Review and Economic Evaluation of Bevacizumab and Cetuximab for the Treatment of Metastatic Colorectal Cancer
Health Technology Assessment
Medicine
Health Policy
Pcn42 - Efficacy of Third Line Tyrosine Kinase Inhibitors for Treatment of Advanced Gastrointestinal Stromal Tumours: Systematic Review and Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of TAS-116, an Oral Inhibitor of Heat Shock Protein 90, in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumour Refractory to Imatinib, Sunitinib and Regorafenib: A Phase II, Single-Arm Trial
European Journal of Cancer
Cancer Research
Oncology
Imatinib-Induced Hepatitis Treated by Corticosteroids in a Patient With Metastatic Gastrointestinal Stromal Tumor
Yeungnam University Journal of Medicine
Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis
PLoS ONE
Multidisciplinary
Relative Hypocalcaemia and Muscle Cramps in Patients Receiving Imatinib for Gastrointestinal Stromal Tumour
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
